Today, the U.S. Food and Drug Administration issued the Center for Drug Evaluation and Research’s (CDER) Drug Safety Priorities 2019 report detailing CDER’s work to manage drug safety issues through modernized safety surveillance methods and innovative responses to safety concerns.
The report highlights key safety-related milestones and accomplishments of 2019, as well as the programs and initiatives at the center of CDER’s drug safety operations, including the Sentinel System and the Safe Use Initiative.
The report focuses on CDER’s ongoing activities to address the national opioid crisis, work in addressing unexpected impurities in medicines, and use of mobile apps and social media platforms to better understand drug safety risks.
.png)
No hay comentarios:
Publicar un comentario